KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) EPS (Weighted Average and Diluted) (2016 - 2025)

Edwards Lifesciences has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.11 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.11 for Q4 2025, down 83.08% from a year ago — trailing twelve months through Dec 2025 was $1.79 (down 74.17% YoY), and the annual figure for FY2025 was $1.81, down 22.65%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.11 at Edwards Lifesciences, down from $0.5 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for EW hit a ceiling of $5.13 in Q3 2024 and a floor of $0.11 in Q4 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.56 (2022), compared with a mean of $0.77.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 714.29% in 2024 and later tumbled 90.25% in 2025.
  • Edwards Lifesciences' EPS (Weighted Average and Diluted) stood at $0.53 in 2021, then plummeted by 37.74% to $0.33 in 2022, then soared by 66.67% to $0.55 in 2023, then rose by 18.18% to $0.65 in 2024, then tumbled by 83.08% to $0.11 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.11 (Q4 2025), $0.5 (Q3 2025), and $0.57 (Q2 2025) per Business Quant data.